https://www.clinicaloncology.com.ua/en/article/30606/clinical-characteristics-treatment-characteristics-and-endpoints-assessed-in-real-world-clinical-practice-of-talazoparib-in-patients-with-her2-negative-brca-associated-breast-cancer